Global DTaP and Tdap Vaccines Market Insights and Forecast to 2026

Global DTaP and Tdap Vaccines Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 DTaP and Tdap Vaccines Product Introduction
1.2 Market Segments
1.3 Key DTaP and Tdap Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Type
1.4.2 DTaP
1.4.3 Td
1.4.4 Tdap
1.5 Market by Application
1.5.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Pediatric
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global DTaP and Tdap Vaccines Market Size, Estimates and Forecasts
2.1.1 Global DTaP and Tdap Vaccines Revenue 2015-2026
2.1.2 Global DTaP and Tdap Vaccines Sales 2015-2026
2.2 Global DTaP and Tdap Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global DTaP and Tdap Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global DTaP and Tdap Vaccines Competitor Landscape by Players
3.1 DTaP and Tdap Vaccines Sales by Manufacturers
3.1.1 DTaP and Tdap Vaccines Sales by Manufacturers (2015-2020)
3.1.2 DTaP and Tdap Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 DTaP and Tdap Vaccines Revenue by Manufacturers
3.2.1 DTaP and Tdap Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global DTaP and Tdap Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by DTaP and Tdap Vaccines Revenue in 2019
3.2.5 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 DTaP and Tdap Vaccines Price by Manufacturers
3.4 DTaP and Tdap Vaccines Manufacturing Base Distribution, Product Types
3.4.1 DTaP and Tdap Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers DTaP and Tdap Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global DTaP and Tdap Vaccines Market Size by Type (2015-2020)
4.1.1 Global DTaP and Tdap Vaccines Sales by Type (2015-2020)
4.1.2 Global DTaP and Tdap Vaccines Revenue by Type (2015-2020)
4.1.3 DTaP and Tdap Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global DTaP and Tdap Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 DTaP and Tdap Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global DTaP and Tdap Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global DTaP and Tdap Vaccines Market Size by Application (2015-2020)
5.1.1 Global DTaP and Tdap Vaccines Sales by Application (2015-2020)
5.1.2 Global DTaP and Tdap Vaccines Revenue by Application (2015-2020)
5.1.3 DTaP and Tdap Vaccines Price by Application (2015-2020)
5.2 DTaP and Tdap Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global DTaP and Tdap Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global DTaP and Tdap Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global DTaP and Tdap Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America DTaP and Tdap Vaccines by Country
6.1.1 North America DTaP and Tdap Vaccines Sales by Country
6.1.2 North America DTaP and Tdap Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America DTaP and Tdap Vaccines Market Facts & Figures by Type
6.3 North America DTaP and Tdap Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe DTaP and Tdap Vaccines by Country
7.1.1 Europe DTaP and Tdap Vaccines Sales by Country
7.1.2 Europe DTaP and Tdap Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe DTaP and Tdap Vaccines Market Facts & Figures by Type
7.3 Europe DTaP and Tdap Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific DTaP and Tdap Vaccines by Region
8.1.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region
8.1.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Type
8.3 Asia Pacific DTaP and Tdap Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America DTaP and Tdap Vaccines by Country
9.1.1 Latin America DTaP and Tdap Vaccines Sales by Country
9.1.2 Latin America DTaP and Tdap Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America DTaP and Tdap Vaccines Market Facts & Figures by Type
9.3 Central & South America DTaP and Tdap Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa DTaP and Tdap Vaccines by Country
10.1.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country
10.1.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa DTaP and Tdap Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Description and Business Overview
11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
11.1.5 Sanofi Pasteur Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Protein Sciences Corporation
11.3.1 Protein Sciences Corporation Corporation Information
11.3.2 Protein Sciences Corporation Description and Business Overview
11.3.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Products Offered
11.3.5 Protein Sciences Corporation Related Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Description and Business Overview
11.4.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis AG DTaP and Tdap Vaccines Products Offered
11.4.5 Novartis AG Related Developments
11.5 Seqirus
11.5.1 Seqirus Corporation Information
11.5.2 Seqirus Description and Business Overview
11.5.3 Seqirus Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Seqirus DTaP and Tdap Vaccines Products Offered
11.5.5 Seqirus Related Developments
11.6 Merck Sharp & Dohme Corp
11.6.1 Merck Sharp & Dohme Corp Corporation Information
11.6.2 Merck Sharp & Dohme Corp Description and Business Overview
11.6.3 Merck Sharp & Dohme Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Products Offered
11.6.5 Merck Sharp & Dohme Corp Related Developments
11.7 Astellas Pharma US, Inc
11.7.1 Astellas Pharma US, Inc Corporation Information
11.7.2 Astellas Pharma US, Inc Description and Business Overview
11.7.3 Astellas Pharma US, Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Products Offered
11.7.5 Astellas Pharma US, Inc Related Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Corporation Information
11.8.2 Pfizer Inc Description and Business Overview
11.8.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Inc DTaP and Tdap Vaccines Products Offered
11.8.5 Pfizer Inc Related Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Description and Business Overview
11.9.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Johnson & Johnson DTaP and Tdap Vaccines Products Offered
11.9.5 Johnson & Johnson Related Developments
11.10 Lanzhou Institute of Biological Products Co., Ltd
11.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
11.10.2 Lanzhou Institute of Biological Products Co., Ltd Description and Business Overview
11.10.3 Lanzhou Institute of Biological Products Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Products Offered
11.10.5 Lanzhou Institute of Biological Products Co., Ltd Related Developments
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Description and Business Overview
11.1.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Products Offered
11.1.5 Sanofi Pasteur Related Developments
11.12 Emergent BioSolutions Inc
11.12.1 Emergent BioSolutions Inc Corporation Information
11.12.2 Emergent BioSolutions Inc Description and Business Overview
11.12.3 Emergent BioSolutions Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Emergent BioSolutions Inc Products Offered
11.12.5 Emergent BioSolutions Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 DTaP and Tdap Vaccines Market Estimates and Projections by Region
12.1.1 Global DTaP and Tdap Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global DTaP and Tdap Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
12.2.2 North America: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: DTaP and Tdap Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa DTaP and Tdap Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: DTaP and Tdap Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: DTaP and Tdap Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: DTaP and Tdap Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key DTaP and Tdap Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 DTaP and Tdap Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. DTaP and Tdap Vaccines Market Segments
Table 2. Ranking of Global Top DTaP and Tdap Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global DTaP and Tdap Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of DTaP
Table 5. Major Manufacturers of Td
Table 6. Major Manufacturers of Tdap
Table 7. Global DTaP and Tdap Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global DTaP and Tdap Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global DTaP and Tdap Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global DTaP and Tdap Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global DTaP and Tdap Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global DTaP and Tdap Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global DTaP and Tdap Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global DTaP and Tdap Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DTaP and Tdap Vaccines as of 2019)
Table 16. DTaP and Tdap Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. DTaP and Tdap Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers DTaP and Tdap Vaccines Price (2015-2020) (USD/Unit)
Table 19. DTaP and Tdap Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers DTaP and Tdap Vaccines Product Type
Table 21. Date of International Manufacturers Enter into DTaP and Tdap Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 24. Global DTaP and Tdap Vaccines Sales Share by Type (2015-2020)
Table 25. Global DTaP and Tdap Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global DTaP and Tdap Vaccines Revenue Share by Type (2015-2020)
Table 27. DTaP and Tdap Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 29. Global DTaP and Tdap Vaccines Sales Share by Application (2015-2020)
Table 30. North America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 31. North America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 35. North America DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 37. North America DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 39. Europe DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 43. Europe DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 45. Europe DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific DTaP and Tdap Vaccines Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 55. Latin America DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 59. Latin America DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 61. Latin America DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Table 70. Sanofi Pasteur Corporation Information
Table 71. Sanofi Pasteur Description and Major Businesses
Table 72. Sanofi Pasteur DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Sanofi Pasteur Product
Table 74. Sanofi Pasteur Recent Development
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Protein Sciences Corporation Corporation Information
Table 81. Protein Sciences Corporation Description and Major Businesses
Table 82. Protein Sciences Corporation DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Protein Sciences Corporation Product
Table 84. Protein Sciences Corporation Recent Development
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Major Businesses
Table 87. Novartis AG DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Novartis AG Product
Table 89. Novartis AG Recent Development
Table 90. Seqirus Corporation Information
Table 91. Seqirus Description and Major Businesses
Table 92. Seqirus DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Seqirus Product
Table 94. Seqirus Recent Development
Table 95. Merck Sharp & Dohme Corp Corporation Information
Table 96. Merck Sharp & Dohme Corp Description and Major Businesses
Table 97. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck Sharp & Dohme Corp Product
Table 99. Merck Sharp & Dohme Corp Recent Development
Table 100. Astellas Pharma US, Inc Corporation Information
Table 101. Astellas Pharma US, Inc Description and Major Businesses
Table 102. Astellas Pharma US, Inc DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Astellas Pharma US, Inc Product
Table 104. Astellas Pharma US, Inc Recent Development
Table 105. Pfizer Inc Corporation Information
Table 106. Pfizer Inc Description and Major Businesses
Table 107. Pfizer Inc DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Pfizer Inc Product
Table 109. Pfizer Inc Recent Development
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Major Businesses
Table 112. Johnson & Johnson DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Johnson & Johnson Product
Table 114. Johnson & Johnson Recent Development
Table 115. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
Table 116. Lanzhou Institute of Biological Products Co., Ltd Description and Major Businesses
Table 117. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Lanzhou Institute of Biological Products Co., Ltd Product
Table 119. Lanzhou Institute of Biological Products Co., Ltd Recent Development
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Major Businesses
Table 122. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. AstraZeneca Product
Table 124. AstraZeneca Recent Development
Table 125. Emergent BioSolutions Inc Corporation Information
Table 126. Emergent BioSolutions Inc Description and Major Businesses
Table 127. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Emergent BioSolutions Inc Product
Table 129. Emergent BioSolutions Inc Recent Development
Table 130. Global DTaP and Tdap Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 131. Global DTaP and Tdap Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global DTaP and Tdap Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global DTaP and Tdap Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: DTaP and Tdap Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 135. North America: DTaP and Tdap Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: DTaP and Tdap Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 137. Europe: DTaP and Tdap Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: DTaP and Tdap Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 139. Asia Pacific: DTaP and Tdap Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: DTaP and Tdap Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 141. Latin America: DTaP and Tdap Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: DTaP and Tdap Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 143. Middle East and Africa: DTaP and Tdap Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key DTaP and Tdap Vaccines Players
Table 148. DTaP and Tdap Vaccines Customers List
Table 149. DTaP and Tdap Vaccines Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. DTaP and Tdap Vaccines Product Picture
Figure 2. Global DTaP and Tdap Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. DTaP Product Picture
Figure 4. Td Product Picture
Figure 5. Tdap Product Picture
Figure 6. Global DTaP and Tdap Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Adult
Figure 8. Pediatric
Figure 9. DTaP and Tdap Vaccines Report Years Considered
Figure 10. Global DTaP and Tdap Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global DTaP and Tdap Vaccines Sales 2015-2026 (K Units)
Figure 12. Global DTaP and Tdap Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global DTaP and Tdap Vaccines Sales Market Share by Region (2015-2020)
Figure 14. Global DTaP and Tdap Vaccines Sales Market Share by Region in 2019
Figure 15. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2015-2020)
Figure 16. Global DTaP and Tdap Vaccines Revenue Market Share by Region in 2019
Figure 17. Global DTaP and Tdap Vaccines Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by DTaP and Tdap Vaccines Revenue in 2019
Figure 19. DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global DTaP and Tdap Vaccines Sales Market Share by Type (2015-2020)
Figure 21. Global DTaP and Tdap Vaccines Sales Market Share by Type in 2019
Figure 22. Global DTaP and Tdap Vaccines Revenue Market Share by Type (2015-2020)
Figure 23. Global DTaP and Tdap Vaccines Revenue Market Share by Type in 2019
Figure 24. Global DTaP and Tdap Vaccines Market Share by Price Range (2015-2020)
Figure 25. Global DTaP and Tdap Vaccines Sales Market Share by Application (2015-2020)
Figure 26. Global DTaP and Tdap Vaccines Sales Market Share by Application in 2019
Figure 27. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2015-2020)
Figure 28. Global DTaP and Tdap Vaccines Revenue Market Share by Application in 2019
Figure 29. North America DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 32. North America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 33. U.S. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America DTaP and Tdap Vaccines Market Share by Type in 2019
Figure 38. North America DTaP and Tdap Vaccines Market Share by Application in 2019
Figure 39. Europe DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 42. Europe DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 43. Germany DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. France DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe DTaP and Tdap Vaccines Market Share by Type in 2019
Figure 54. Europe DTaP and Tdap Vaccines Market Share by Application in 2019
Figure 55. Asia Pacific DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Region in 2019
Figure 58. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Region in 2019
Figure 59. China DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 60. China DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. India DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific DTaP and Tdap Vaccines Market Share by Type in 2019
Figure 82. Asia Pacific DTaP and Tdap Vaccines Market Share by Application in 2019
Figure 83. Latin America DTaP and Tdap Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America DTaP and Tdap Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America DTaP and Tdap Vaccines Sales Market Share by Country in 2019
Figure 86. Latin America DTaP and Tdap Vaccines Revenue Market Share by Country in 2019
Figure 87. Mexico DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina DTaP and Tdap Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina DTaP and Tdap Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America DTaP and Tdap Vaccines Market Share by

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs